Skip to Main Content

Paper Details

A randomized phase II study of gemcitabine and carboplatin with or without cediranib as first-line therapy in advanced non-small-cell lung cancer: North Central Cancer Treatment Group Study N0528.
J Thorac Oncol
38
2013

Datasets

Release 1.2